Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 4 (1)

Trial Status

Recruiting3
Not Yet Recruiting1
Unknown1
Enrolling By Invitation1

Clinical Trials (6)

Showing 6 of 6 trials
NCT07392359Not ApplicableNot Yet RecruitingPrimary

Zhicheng TAVR Robot

NCT06689839Not ApplicableRecruitingPrimary

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

NCT07059728Not ApplicableRecruitingPrimary

High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II

NCT07045233Enrolling By Invitation

A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke

NCT06756282Recruiting

One Year Pacing Dependency After TAVR

NCT04346004Phase 4UnknownPrimary

Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation

Showing all 6 trials

Research Network

Activity Timeline